Literature DB >> 6191891

Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies.

J Ivanyi, S Sinha, R Aston, D Cussell, M Keen, U Sengupta.   

Abstract

Four soluble antigens of Mycobacterium leprae have been identified using 12 murine monoclonal antibodies. Their specificity, taxonomic distribution and molecular nature were analysed by radioimmunoassays and by immunoblotting from polyacrylamide electrophoresis gels. A protein antigen MY1 (12K) reacted with one antibody (ML06) without demonstrable cross-reactivity for any of the other 20 tested species of mycobacteria. Another four antibodies which identified antigen MY2 revealed only a marginal degree of cross-reactivity with three other species of mycobacteria. Two antigens shared by several other mycobacteria species were: MY3 represented by five protein bands (35-70K) and a subtilisin resistant molecule MY4 (40-50K) with two distinct determinants and presumably of polysaccharide nature. The described monoclonal antibodies may represent novel valuable diagnostic reagents as well as tools for the purification of antigens which could be explored towards prophylactic or therapeutic immunization against leprosy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191891      PMCID: PMC1536026     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Repertoire of antiviral antibodies expressed by somatic cell hybrids.

Authors:  W Gerhard; C M Croce; D Lopes; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Studies on the antigenic specificity of Mycobacterium leprae. I. Demonstration of soluble antigens in leprosy nodules by immunodiffusion.

Authors:  M Abe
Journal:  Int J Lepr Other Mycobact Dis       Date:  1970 Apr-Jun

4.  Cell walls of Mycobacterium leprae.

Authors:  P Draper
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

5.  Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo.

Authors:  W F Kirchheimer; E E Storrs
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Jul-Sep

6.  Preliminary taxonomic studies on the leprosy bacillus.

Authors:  J L Stanford; G A Rook; J Convit; T Godal; G Kronvall; R J Rees; G P Walsh
Journal:  Br J Exp Pathol       Date:  1975-12

7.  Studies of mycobacterial antigens, with special reference to Mycobacterium leprae.

Authors:  G Kronvall; J L Stanford; G P Walsh
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

8.  Antigenic analysis of Mycobacterium leprae.

Authors:  O Closs; R N Mshana; M Harboe
Journal:  Scand J Immunol       Date:  1979-03       Impact factor: 3.487

9.  Subclass restriction of murine anti-carbohydrate antibodies.

Authors:  R M Perlmutter; D Hansburg; D E Briles; R A Nicolotti; J M Davie
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  55 in total

1.  An interaction between p21ras and heat shock protein hsp60, a chaperonin.

Authors:  S Ikawa; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Production and epitope analysis of monoclonal antibodies against a Rhizobium leguminosarum biovar trifolii strain.

Authors:  S F Wright
Journal:  Appl Environ Microbiol       Date:  1990-07       Impact factor: 4.792

3.  Enzyme-linked immunosorbent assay for distinguishing serological responses of lepromatous and tuberculoid leprosies to the 29/33-kilodalton doublet and 64-kilodalton antigens of Mycobacterium tuberculosis.

Authors:  P K Das; A Rambukkana; J G Baas; D G Groothuis; M Halperin
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Induction of heat shock protein 60 expression in human monocytic cell lines infected with Mycobacterium leprae.

Authors:  K Beimnet; K Söderström; S Jindal; A Grönberg; D Frommel; R Kiessling
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Results of a World Health Organization-sponsored workshop on monoclonal antibodies to Mycobacterium leprae.

Authors: 
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  Screening of a recombinant mycobacterial DNA library with polyclonal antiserum and molecular weight analysis of expressed antigens.

Authors:  D B Young; L Kent; R A Young
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

7.  Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall.

Authors:  T P Gillis; R A Miller; D B Young; S R Khanolkar; T M Buchanan
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

8.  Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera.

Authors:  P R Klatser; M M van Rens; T A Eggelte
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens.

Authors:  S P Lee; N G Stoker; K A Grant; Z T Handzel; R Hussain; K P McAdam; H M Dockrell
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

10.  Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.

Authors:  A H Kolk; M L Ho; P R Klatser; T A Eggelte; S Kuijper; S de Jonge; J van Leeuwen
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.